NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1050210014

Registered date:06/05/2021

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedCOVID-19
Date of first enrollment06/05/2021
Target sample size200
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcome1) Anti-Ig levels in blood 2) T-cell response in peripheral blood 3) Phenotypes of immune cells in peripheral blood
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Gender
Include criteria1) Subjects working at Kyoto University and aged 20 years old or older at informed consent with no major medical history and other medical problems 2) Subjects aged 65 years old or older at informed consent with no major medical history 3) Subjects who have obtained written consent voluntarily to participate in this trial 4) Subjects who are scheduled to receive COVID-19 vaccination
Exclude criteria1) Subjects who have been administered with drugs that affect the immune system (excluding external preparations) such as immunomodulators (DMARDs, etc.), immunosuppressants, biologics, etc. 2) Subjects who are tested positive for human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), or HTLV-1. 3) Subjects who are otherwise ineligible for this study in the principal investigator's or subinvestigator's opinion.

Related Information

Contact

Public contact
Name Yoko Hamazaki
Address Kyoto Japan 6068507
Telephone +81-753667327
E-mail yoko.hamazaki@cira.kyoto-u.ac.jp
Affiliation Center for iPS Cell Research and Application, Kyoto University
Scientific contact
Name Yoko Hamazaki
Address Kyoto Japan 6068507
Telephone +81-7536673267
E-mail yoko.hamazaki@cira.kyoto-u.ac.jp
Affiliation Center for iPS Cell Research and Application, Kyoto University